November 2019 Vol. 7 No.11

Abstract
Full text
Reprint (PDF) (315 KB)

Search Pubmed for articles by:
 

Case Report

Amiodarone – a rare cause of acute hepatitis – case presentation

Violeta Sapira¹, Anca Telehuz², Mihai Polinschi³, Alexandru Nechifor³, Valerica Zarnescu Creanga³ and
Mihaela Lungu^1*

¹Emergency Clinical County Hospital “Sfantul Apostol Andrei” Galati, “Dunarea de Jos” University of Galati
²Slobozia Emergency County Hospital, Romania
³“Faculty of Medicine and Pharmacy, “Dunarea de Jos” University of Galati, Romania

*Corresponding Author’s E-mail: micalungu@gmail.com

Accepted November 27, 2019

Abstract

Amiodarone, a Class III antiarrhythmic agent, used in the treatment of supraventricular and ventricular tachyarrhythmias, may cause acute hepatitis. Although it is a rare complication, it can be fatal. We presented the case of a 59-year-old patient without any personal pathological background, chronic medication and cardiovascular risk factors, who came in the emergency Department where he is diagnosed with atrial fibrillation. Intravenous amiodarone treatment is instituted, but at 12 hours after initiation of treatment, there is a significant increase in the level of hepatic transaminases. The diagnosis of acute hepatitis is made, possibly drug-related. After we stopped the amiodarone administration, the evolution is favorable, with the remission of the cytolysis syndrome. This case highlights the need for careful monitoring of patients receiving intravenous amiodarone to identify any potential for hepatotoxicity.

Keywords: Intravenous amiodarone, acute hepatotoxicity, hepatic transaminases, amiodarone induced liver injury